Post-earnings recap
Reported
Tue, Feb 21, 2017
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
The earnings report shows that Medtronic managed to exceed EPS expectations, which likely contributed to the 2.13% increase in stock price. Investors may be encouraged by management's positive outlook on product performance and commitment to growth. However, the lack of revenue data and forward guidance leaves some uncertainty about future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.12 | N/A | +0.99% |
| Revenue | N/A | N/A | N/A |
Overall, management expressed confidence in the company's direction despite not providing specific guidance. They noted positive trends in product demand.
Management highlighted strong performance in key product areas.
They emphasized ongoing commitment to innovation and market expansion.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—